MDRX - Allscripts Healthcare Solutions Q2 Non-GAAP EPS misses revenue beats FY22 outlook reaffirmed
- Allscripts Healthcare Solutions press release ( NASDAQ: MDRX ): Q2 Non-GAAP EPS of -$63.60 (vs. $21.9 Y/Y) misses by $63.75 .
- Revenue of $150.9M (+6.9% Y/Y) beats by $2.32M .
- Allscripts is affirming its prior annual outlook (consensus EPS $0.74 and consensus revenue $613.21M).
For further details see:
Allscripts Healthcare Solutions Q2 Non-GAAP EPS misses, revenue beats, FY22 outlook reaffirmed